News & Events
iCAD & ProFound Breast Health Suite in the News
Press Releases
iCAD Reports Financial Results for First Quarter Ended March 31, 2025
NASHUA, N.H. – May 13, 2025 – iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the three months ended March 31, 2025. …
iCAD Collaborates with Microsoft to provide access to its Mammography Solutions in Microsoft’s Precision Imaging Network (PIN)
iCAD collaborates with Microsoft to offer radiology providers the option for automated patient reporting on mammography results through PowerScribe integration NASHUA, N.H., April 29, 2025 — iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”), a global leader in clinically proven AI-powered cancer detection solutions, announced today a collaboration with Microsoft,…
RadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Early Detection and Diagnosis of Breast Cancer
Los Angeles, CA and Nashua, NH – April 15, 2025, RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, and iCAD, Inc. (NASDAQ: ICAD) (“iCAD”), a global leader in providing clinically proven AI-powered breast health solutions, announced today that they…
In the Media
How AI Transforms Early Breast Cancer Detection, and Improves Outcomes
healthandpharma.net: Oncolife
Upcoming Tradeshows & Meetings
SIIM 2025 Annual Meeting – Society for Imaging Informatics in Medicine
Her breast health journey deserves trust and confidence—empower it with iCAD’s AI-powered solutions, offering faster, more precise insights to help you deliver exceptional care today—and tomorrow. With iCAD, reduce diagnostic uncertainty and ensure she gets the right care at the right time, giving her confidence and peace of mind.
The 11th International Breast Density & Cancer Risk Assessment Workshop
Her breast health journey deserves trust and confidence—empower it with iCAD’s AI-powered solutions, offering faster, more precise insights to help you deliver exceptional care today—and tomorrow. With iCAD, reduce diagnostic uncertainty and ensure she gets the right care at the right time, giving her confidence and peace of mind.
Webinars
Case Review with ProFound AI Detection Solutions, Presented by Dr. Rafaele Vautrin, Radiologist at Imapole Lyon Villeurbanne
Dr. Vautrin, a user of iCAD’s ProFound AI solution for 2D and 3D mammography for nearly two years, shares her experience through a series of clinical cases where the AI-provided insights were crucial in detecting cancer in her patients.
Symposium JFR 2024
Apport des solutions d’intelligence artificielle d’iCAD pour un meilleur dépistage du cancer du sein détection, densité et risque : revue des dernières études cliniques et revue de cas. Présenté par Pr Bruno Boyer, CIMI, Paris
Revue de cas cliniques avec les solutions ProFound AI détection, présentés par le Dr Rafaele Vautrin, Radiologue à Imapole Lyon Villeurbanne.
Utilisatrice de la solution ProFound IA d’iCAD pour les mammographies 2D et 3D depuis près de deux ans, le Dr Vautrin partage son retour d’expérience au travers d’une dizaine de cas cliniques pour lesquels les informations fournies par l’IA se sont avérées déterminantes pour détecter des cancers chez ses patientes.
Contact Us
Together, we can create a world where cancer can’t hide.
Ready to experience how ProFound can save lives?